Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
To determine whether 1-tyrosine administration can enhance dopamine synthesis in humans as it does in rats, we measured levels of tyrosine and the major dopamine metabolite, homovanillic acid, in lumbar spinal fluids of 23 patients with Parkinson's disease before and during ingestion of 100 mg/kg/day of tyrosine. Nine patients took 100 mg/kg/day of probenecid in six divided doses for 24 hours prior to each spinal tap; 14 patients did not receive probenecid. L-tyrosine administration significantly increased CSF tyrosine levels in both groups of patients (p less than .01) and significantly increased homovanillic acid levels in the group of patients pretreated with probenecid (p less than .02). These data indicate that l-tyrosine administration can increase dopamine turnover in patients with disorders in which physicians wish to enhance dopaminergic neurotransmission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, administration of L-tyrosine previously increased plasma levels of dopamine’s metabolite homovanillic acid in Parkinson’s patients (Growdon, Melamed, Logue, Hefti, & Wurtman, 1982), as well as plasma levels of noradrenaline in healthy volunteers (Kishore et al., 2013).”
From Baseline-dependent effect of dopamine’s precursor L-tyrosine on working memory gating but not updating (2020) · cites this paper as Growdon et al., 1982
Citations
Cites
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
A fluorometric method for the estimation of tyrosine in plasma and tissues.
Waalkes, T. P., & Udenfriend, S. (1957) · PubMed · Cited by 973
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization
Hefti, F., Melamed, E., & Wurtman, R. J. (1980) · Brain Research · doi:10.1016/0006-8993(80)90871-9 · Cited by 501
Self-citationNEUTRAL AMINO ACIDS IN THE BRAIN: CHANGES IN RESPONSE TO FOOD INGESTION1
Fernstrom, J. D., & Faller, D. V. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10489.x · Cited by 423
Brain Catechol Synthesis: Control by Brain Tyrosine Concentration
Wurtman, R. J., Larin, F., Mostafapour, S., & Fernstrom, J. D. (1974) · Science · doi:10.1126/science.185.4146.183 · Cited by 367
Self-citationAGID, Y., JAVOY, F., & GLOWINSKI, J. (1973) · Nature New Biology · doi:10.1038/newbio245150a0 · Cited by 366
BITO, L., Davson, H., Levin, E., Murray, M., & Snider, N. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb04265.x · Cited by 352
Carlsson, A., & Lindqvist, M. (1978) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00508062 · Cited by 326
Physiological control of brain norepinephrine synthesis by brain tyrosine concentration
Gibson, C. J., & Wurtman, R. J. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90633-1 · Cited by 204
Self-citationCSF amino acids and plasma‐CSF amino acid ratios in adults1
Perry, T. L., Hansen, S., & Kennedy, J. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb07680.x · Cited by 194
Research works printed but not linked: 2
- Waakles, 1957, J. Lab. Clin. Med., 50, 733
- Melamed, 1980, 77, 4305
Cited by
Intercalation of drugs in layered double hydroxides and their controlled release: A review
Rives, V., del Arco, M., & Martín, C. (2014) · Applied Clay Science · doi:10.1016/j.clay.2013.12.002 · Cited by 403
Animal Models of Parkinsonism Using Selective Neurotoxins: Clinical and Basic Implications
Zigmond, M. J., & Stricker, E. M. (1989) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60277-9 · Cited by 199
Psychotropic substance‐seeking: evolutionary pathology or adaptation?
Sullivan, R. J., & Hagen, E. H. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00024.x · Cited by 191
“The sensitivity of the CNS to the external provision of NTs is evident in that dietary precursors alone have been used to increase monoamine turnover as a treatment for depression (Chouinard et al. 1979; Gelenberg et al. 1980; see also Growdon et al. 1982 in Parkinson's disease).”
BackgroundJongkees, B. J., Hommel, B., Kühn, S., & Colzato, L. S. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.08.014 · Cited by 183
“Interestingly, an early study showed administering TYR to Parkinson's patients raised levels of DA's metabolite homovanillic acid, suggesting TYR effectively promoted DA function (Growdon et al., 1982).”
BackgroundCan nutrient supplements modify brain function?
Fernstrom, J. D. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1669s · Cited by 165
“Growdon et al (45) showed that tyrosine elevated dopamine production in the CNS of patients with Parkinson disease, a serious, debilitating disorder, the cause of which is thought to involve a loss of dopamine neurons and which is typically treated by administering the immediate dopamine precursor, L-dopa.”
Background
Metadata
- Authors
- Growdon, J. H., Melamed, E., Logue, M., Hefti, F., & Wurtman, R. J.
- Affiliations
- Tufts Medical Center (US)
- Massachusetts Institute of Technology (US)
- ORCID
- Hefti, Franz
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 1982-03
- Volume
- 30
- Issue
- 10
- Pages
- 827-832
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2075093684
- Cited by
- 91
- References
- 21
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 3
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Parkinson Disease Association
- Parkinson Vereniging
- National Institutes of Health
- U.S. Public Health Service
- Fogarty International Center
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- tyrosine, Parkinson's disease, homovanillic acid, cerebrospinal fluid, dopamine synthesis, dopamine turnover, probenecid, lumbar puncture, dopamine signaling
- MeSH terms
- Administration, Oral, Chromatography, High Pressure Liquid, Homovanillic Acid, Humans, Hydroxyindoleacetic Acid, Parkinson Disease, Phenylacetates, Probenecid, Tyrosine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. https://app.cochat.ai/papers/10.1016/0024-3205(82)90596-3
- The paper
- Growdon, J. H., Melamed, E., Logue, M., Hefti, F., & Wurtman, R. J. (1982). Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sciences. https://doi.org/10.1016/0024-3205(82)90596-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.